Ophthalmology

The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.

Latest News

Woman with glaucoma | Image credit: Africa Studio - stock.adobe.com
Thinning in GCIPL, RNFL Different in Glaucoma Subtypes

January 8th 2025

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was different in people with primary open angle glaucoma and pseudoexfoliation glaucoma.

Woman taking eye exam | Image credit: Rabizo Anatolii - stock.adobe.com
Response Times to Visual Stimulus Slower in Patients With Glaucoma

January 3rd 2025

Test for AMD | Image credit: RFBSIP - stock.adobe.com
Intravitreal Faricimab Associated With Increased Treatment Interval, Decreased CST

December 23rd 2024

Top 5 Ophthalmology Articles of 2024
Top 5 Most-Read Ophthalmology Articles of 2024

December 23rd 2024

Retinopathy | Image credit: NanSan - stock.adobe.com
Hyperglycemia Biggest Risk Factor in Retinopathy

December 18th 2024

Continuing Medical Education
View All
January 15th 2025

Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care

2.0 Credits / Ophthalmology/Optometry
January 15th 2025

Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies

1.5 Credits / Ophthalmology, Optometry
January 15th 2025

Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adherence and Outcomes

1.5 Credits / Ophthalmology/Optometry
January 15th 2025

Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals

1.5 Credits / Oncology
January 15th 2025

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

More News

Expanded School-Based Vision Testing May Help Address Disparities, Study Says
October 16th 2023

Expanded School-Based Vision Testing May Help Address Disparities, Study Says

Julia Bonavitacola
Age played a part in the decrease in vision testing in adolescents, along with fewer reported tests in primary and school-based settings.
Higher Rate of Diabetic Retinopathy Found in Patients With LEP
October 11th 2023

Higher Rate of Diabetic Retinopathy Found in Patients With LEP

Julia Bonavitacola
Patients with limited English proficiency (LEP) who presented for cataract surgery had a higher rate of diabetic retinopathy compared with patients with English proficiency.
Choriocapillaris Flow Signal Deficits Associated With AMD Severity
October 6th 2023

Choriocapillaris Flow Signal Deficits Associated With AMD Severity

Julia Bonavitacola
Age-related macular degeneration (AMD) and impaired vision were found to be associated with choriocapillaris flow signal deficits in patients 60 years and older.
RNFL Thickness Associated With Pseudophakic Cystoid Macular Edema
October 2nd 2023

RNFL Thickness Associated With Pseudophakic Cystoid Macular Edema

Julia Bonavitacola
Eyes of patients with pseudophakic cystoid macular edema demonstrated greater retinal nerve fiber layer (RNFL) thickness compared with healthy eyes.
AI Effective in Screening for Referable Diabetic Retinopathy
September 27th 2023

AI Effective in Screening for Referable Diabetic Retinopathy

Julia Bonavitacola
In a real-world setting, artificial intelligence (AI) proved to be effective in screening for referable diabetic retinopathy.
Study Confirms Retinal Structural Associations Between Retinitis Pigmentosa, Macular Edema
September 21st 2023

Study Confirms Retinal Structural Associations Between Retinitis Pigmentosa, Macular Edema

Julia Bonavitacola
Researchers also suggest potential new genetic associations with macular edema, which warrant further research.
Differences in Ophthalmology Residents’ Medical Knowledge Ratings Could Indicate Gender Disparities
September 18th 2023

Differences in Ophthalmology Residents’ Medical Knowledge Ratings Could Indicate Gender Disparities

Julia Bonavitacola
Although major gender bias on the national level was not found, differences in medical knowledge (MK) ratings could be an indicator of gender bias in ophthalmology education.
Money
September 11th 2023

Drug Manufacturer Payments Associated With Prescribing Higher-Cost Therapies for ARMD

Julia Bonavitacola
Higher-cost therapies for age-related macular edema (ARMD) were significantly more likely to be prescribed by ophthalmologists accepting manufacturer payments.
E-Cigarette
September 5th 2023

E-Cigarette, Cigarette Users Have Higher Likelihood of Ocular Symptoms

Julia Bonavitacola
Severe and frequent ocular symptoms were more likely in adolescents and young adults who used e-cigarettes and cigarettes.
Eye
September 3rd 2023

Macular Thickness Maps Effective Tools in Remote Monitoring of eAMD

Julia Bonavitacola
Recurrent exudations in patients with exudative age-related macular degeneration (eAMD) can be sufficiently monitored with macular thickness maps alone.
blurry woman with her eye in focus
August 31st 2023

FDA Approves Higher-Dose Version of Aflibercept

Skylar Jeremias
The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy.
Man with glasses
August 21st 2023

Polygenic Risk Score Identifies Individuals at Higher Risk of POAG

Julia Bonavitacola
Individuals with a higher risk of primary open-angle glaucoma (POAG) could be identified using a polygenic risk score, recent study found.
Eye
August 17th 2023

Vision Testing Lowest in Adolescents Without Insurance

Julia Bonavitacola
A recent study found that children who had private insurance had a higher probability of vision testing compared with uninsured and publicly insured children.
Woman's eyes
August 14th 2023

Leakage Index Associated With Macular Edema Severity

Julia Bonavitacola
Patients with nonischemic branch retinal vein occlusion had their macular edema severity associated with leakage index.
FDA Approved
August 7th 2023

FDA Approves New Treatment for Geographic Atrophy

Julia Bonavitacola
The FDA approved the usage of Izervay (avacincaptad pegol) for the treatment of geographic atrophy secondary to age-related macular degeneration.
ASRS 2023: Intended vs Actual Treatment Intervals Between Intravitreal Anti-VEGF Injections: Effects of Treatment Days
August 4th 2023

ASRS 2023: Intended vs Actual Treatment Intervals Between Intravitreal Anti-VEGF Injections: Effects of Treatment Days

Lynda Charters
In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.
e-Cigarette
August 2nd 2023

Smokeless Tobacco More Likely to Cause AMD, Study Suggests

Julia Bonavitacola
Adults who used smokeless tobacco products were more likely to have age-related macular degeneration (AMD) compared with cigarette smokers.
Eye
July 27th 2023

Exposure to Statins Not Related to Increased Risk of OAG

Julia Bonavitacola
A study conducted in Japan found that short-term exposure to statins was not associated with an increased risk of open-angle glaucoma (OAG) in a population with dyslipidemia.
Eye
July 24th 2023

Expansion of Laser Eye Surgery Not Associated With Shorter Travel Times for Care

Julia Bonavitacola
Having optometrists perform laser eye surgery was not found to lead to a meaningful increase in nearby health care professionals for the population.
Man with glasses
July 21st 2023

Low Vision Rehabilitation Recommended for Patients With ARMD

Julia Bonavitacola
Patients with age-related macular degeneration (ARMD) with geographic atrophy should use low vision aids.
Eye drops
July 17th 2023

Atropine 0.01% Not Associated With Slowing Myopia Progression

Julia Bonavitacola
A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression.
Group of doctors
July 12th 2023

In Vitreoretinal Subspecialty, Men Have More Publications, Occupy Higher Academic Positions

Julia Bonavitacola
A search of residency programs in the United States found that women made up about a quarter of all academic vitreoretinal specialists.
Laptop
July 10th 2023

Novel Smartphone App Effective in Assessing Pediatric Ophthalmology

Julia Bonavitacola
A smartphone app was found to be useful and reliable by clinicians when testing vision for children during the COVID-19 pandemic.
Baby
July 5th 2023

Retinopathy of Prematurity Risk Linked to Parenteral Nutrition Duration

Julia Bonavitacola
Infants who received parenteral nutrition for at least 14 days had a higher risk of retinopathy of prematurity and receiving treatment.
Man with glasses
June 26th 2023

Prevalence of Eye Disease Related to Diabetes Remains High in United States

Julia Bonavitacola
A new study estimated that 9.60 million people are living with diabetic retinopathy and 1.84 million people are living with vision-threatening diabetic retinopathy in the United States.
Eye
June 19th 2023

Microbial Keratitis Severity Associated With Patient Characteristics, Location

Julia Bonavitacola
Social risk factors, such as patient characteristics and where they live, informed the severity of microbial keratitis in a sample of patients.
Eye with technology overlay
June 13th 2023

Artificial Intelligence Has Potential to Estimate BCVA in Patients With DME

Julia Bonavitacola
Fundus photographs of eyes with diabetic macular edema (DME) could be used to estimate best-corrected visual acuity (BCVA) when artificial intelligence examines the pictures.
Children
June 9th 2023

Low-dose Atropine for Pediatric Myopia Progression Found Effective in Phase 3 Trial

Julia Bonavitacola
Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study.
Eye
May 30th 2023

Infliximab, Adalimumab Have Similar Efficacy in Patients With Noninfectious Uveitis

Julia Bonavitacola
Adalimumab had a slight advantage over infliximab in terms of adverse events when used to treat patients with noninfectious uveitis (NIU).
Screenshot of Byron Lam, MD
May 29th 2023

Dr Byron Lam Discusses Impact on SES Factors on Glaucoma Screening Follow-up

Laura Joszt, MA
Insurance is by far the most important factor of whether patients followed up with treatment after getting screened for glaucoma, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.
<12345678
...
17>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo